Predictions
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€2.24
19.11.21
19.11.21
€2.60
19.11.22
19.11.22
-69.80%
20.11.22
20.11.22
Could be worthwhile Investment >10% per year
AB Science S.A.
Start price
Target price
Perf. (%)
€12.40
19.11.21
19.11.21
€13.60
19.11.22
19.11.22
-34.44%
20.11.22
20.11.22
Could be worthwhile Investment >10% per year
Crossject S.A.
Start price
Target price
Perf. (%)
€2.82
18.11.21
18.11.21
€2.50
18.11.22
18.11.22
66.84%
16.08.22
16.08.22
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€2.24
17.11.21
17.11.21
€1.80
17.11.22
17.11.22
0.00%
19.11.21
19.11.21
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€21.24
15.11.21
15.11.21
€25.00
15.11.22
15.11.22
33.24%
27.11.21
27.11.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Genomic Vision S.A.
Start price
Target price
Perf. (%)
€0.30
12.11.21
12.11.21
€0.50
12.11.22
12.11.22
-78.55%
13.11.22
13.11.22
Could be worthwhile Investment >10% per year
Nanobiotix
Start price
Target price
Perf. (%)
€8.51
11.11.21
11.11.21
€10.00
11.11.22
11.11.22
-53.17%
12.11.22
12.11.22
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€2.19
11.11.21
11.11.21
-
11.11.22
11.11.22
2.28%
17.11.21
17.11.21
Could be worthwhile Investment >10% per year
bioMerieux S.A.
Start price
Target price
Perf. (%)
€106.50
08.11.21
08.11.21
€110.00
08.11.22
08.11.22
-12.21%
09.11.22
09.11.22
Could be worthwhile Investment >10% per year
bioMerieux S.A.
Start price
Target price
Perf. (%)
€107.60
07.11.21
07.11.21
€100.00
07.11.22
07.11.22
-1.02%
08.11.21
08.11.21
Could be worthwhile Investment >10% per year
Virbac S.A.
Start price
Target price
Perf. (%)
€401.50
07.11.21
07.11.21
€385.00
07.11.22
07.11.22
-38.36%
22.10.22
22.10.22
Could be worthwhile Investment >10% per year
Genoway S.A. Inh.
Start price
Target price
Perf. (%)
€4.37
07.11.21
07.11.21
€4.10
07.11.22
07.11.22
-19.68%
22.10.22
22.10.22
Could be worthwhile Investment >10% per year
Mauna Kea Tech
Start price
Target price
Perf. (%)
€0.84
07.11.21
07.11.21
€1.10
07.11.22
07.11.22
-33.61%
08.11.22
08.11.22
Could be worthwhile Investment >10% per year
Transgene S.A.
Start price
Target price
Perf. (%)
€2.43
07.11.21
07.11.21
€2.80
07.11.22
07.11.22
-20.58%
08.11.22
08.11.22
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€19.59
31.10.21
31.10.21
€30.00
31.10.22
31.10.22
8.63%
13.11.21
13.11.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Virbac S.A.
Start price
Target price
Perf. (%)
€395.50
25.10.21
25.10.21
€480.00
25.10.22
25.10.22
1.52%
07.11.21
07.11.21
Could be worthwhile Investment >10% per year
Korian S.A.
Start price
Target price
Perf. (%)
€28.30
17.10.21
17.10.21
€30.00
17.10.22
17.10.22
-62.44%
18.10.22
18.10.22
Could be worthwhile Investment >10% per year
Cellectis Nom.
Start price
Target price
Perf. (%)
€9.20
15.10.21
15.10.21
€11.50
15.10.22
15.10.22
-61.67%
07.08.22
07.08.22
Could be worthwhile Investment >10% per year
Oncodesign S.A.
Start price
Target price
Perf. (%)
€10.08
09.10.21
09.10.21
€12.00
09.10.22
09.10.22
-20.04%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Poxel S.A.
Start price
Target price
Perf. (%)
€5.86
07.10.21
07.10.21
€7.50
07.10.22
07.10.22
-8.28%
24.11.21
24.11.21
Could be worthwhile Investment >10% per year
Novacyt S.A.
Start price
Target price
Perf. (%)
€3.24
04.10.21
04.10.21
€4.50
04.10.22
04.10.22
-71.33%
05.10.22
05.10.22
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€12.95
03.10.21
03.10.21
€20.00
03.10.22
03.10.22
15.83%
16.10.21
16.10.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business